Our top pick for
Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
Pareteum Corporation is a software-application business based in the US. Pareteum Corporation shares (TEUM) are listed on the PINK and all prices are listed in US Dollars. Pareteum Corporation employs 199 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$0.05|
|52-week range||$0.09 - $0.74|
|50-day moving average||$0.14|
|200-day moving average||$0.29|
|Wall St. target price||$0.75|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.31|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
|1 week (2021-10-15)||-60.63%|
|1 month (2021-09-24)||-64.39%|
|3 months (2021-07-23)||-83.87%|
|6 months (2021-04-23)||-88.37%|
|1 year (2020-10-23)||-92.76%|
|2 years (2019-10-24)||-88.55%|
|3 years (2018-10-24)||2.25|
|5 years (2016-10-24)||0.1824|
Valuing Pareteum Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Pareteum Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Pareteum Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $2.6 million.
The EBITDA is a measure of a Pareteum Corporation's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$65 million|
|Gross profit TTM||$20.7 million|
|Return on assets TTM||-45.19%|
|Return on equity TTM||-349.11%|
|Market capitalisation||$6.4 million|
TTM: trailing 12 months
There are currently 14.3 million Pareteum Corporation shares held short by investors – that's known as Pareteum Corporation's "short interest". This figure is 3.7% up from 13.7 million last month.
There are a few different ways that this level of interest in shorting Pareteum Corporation shares can be evaluated.
Pareteum Corporation's "short interest ratio" (SIR) is the quantity of Pareteum Corporation shares currently shorted divided by the average quantity of Pareteum Corporation shares traded daily (recently around 1.1 million). Pareteum Corporation's SIR currently stands at 13.16. In other words for every 100,000 Pareteum Corporation shares traded daily on the market, roughly 13160 shares are currently held short.
However Pareteum Corporation's short interest can also be evaluated against the total number of Pareteum Corporation shares, or, against the total number of tradable Pareteum Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Pareteum Corporation's short interest could be expressed as 0.11% of the outstanding shares (for every 100,000 Pareteum Corporation shares in existence, roughly 110 shares are currently held short) or 0.111% of the tradable shares (for every 100,000 tradable Pareteum Corporation shares, roughly 111 shares are currently held short).
A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Pareteum Corporation.
Find out more about how you can short Pareteum Corporation stock.
We're not expecting Pareteum Corporation to pay a dividend over the next 12 months.
Pareteum Corporation's shares were split on a 1:25 basis on 26 February 2017. So if you had owned 25 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Pareteum Corporation shares – just the quantity. However, indirectly, the new 2400% higher share price could have impacted the market appetite for Pareteum Corporation shares which in turn could have impacted Pareteum Corporation's share price.
Over the last 12 months, Pareteum Corporation's shares have ranged in value from as little as $0.09 up to $0.735. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (PINK average) beta is 1, while Pareteum Corporation's is 0.5534. This would suggest that Pareteum Corporation's shares are less volatile than average (for this exchange).
Pareteum Corporation, a cloud software communications platform company, provides communications platform-as-a-service (CPaaS) solutions in the United States and internationally. Its platform offers mobility, messaging, and connectivity and security services and applications. The company's platform hosts integrated IT/back office and core network functionality for mobile network operators, as well as for enterprises to implement and leverage mobile communications solutions on a software-as-a-service (SaaS), PaaS, and/or infrastructure-as-a-service basis. It also delivers operational support system for channel partners with application program interfaces for integration with third party systems, workflows for complex application orchestration, and customer support with branded portals and plug-ins for various other applications. In addition, the company provides software solutions, which layer over disparate fixed, mobile, and IP networks to enable the deployment of converged communication services and applications for enterprise communications and core telecommunications markets; and Wi-Fi access on mobile devices through its SaaS platform. It serves the markets of Internet of Things, smart cities, and application developers, as well as mobile virtual network operators, enablers and aggregators. The company was formerly known as Elephant Talk Communications Corp.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.